{
  "id": "mhgap#risk_safety_fa28d4b0",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders 201. Ciray RO, Hancer P, Tuncturk M, Emiroglu 209. mhGAP operations manual. Geneva: World NI. [Placebo-controlled pharmacological Health Organization; 2018 (https://iris.who.int/ trials in child and adolescents with bipolar handle/10665/275386). disorder manic episode (BPD-ME): systematic 210. Bighelli I, Rodolico A, García-Mieres H, Pitschel- review, meta-analysis and a meta-regression Walz G, Hansen WP, Schneider-Thoma J et al. on placebo response] (in Turkish). Turkish J Psychosocial and psychological interventions Clinical Psychiatry. 2020;23:375–85 (https://doi. for relapse prevention in schizophrenia: a org/10.5505/kpd.2020.45822). systematic review and network meta-analysis. 202. Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Lancet Psychiatry. 2021;8(11):969–80 (https://doi. Nomura I et al. Pharmacological treatment for org/10.1016/S2215-0366(21)00243-1). bipolar mania: a systematic review and network 211. Oud M, Mayo-Wilson E, Braidwood R, Schulte meta-analysis of double-blind randomized P, Jones SH, Morriss R et al. Psychological controlled trials. Mol Psychiatry. 2022;27(2):1136– interventions for adults with bipolar disorder: 44 (https://doi.org/10.1038/s41380-021-01334-4). systematic review and meta-analysis. Br J 203. Farkas R, Feeney J. Clinical review, adverse events: Psychiatry. 2016;208(3):213–22 (https://doi. carbamazepine. East Hanover (NJ): Novartis org/10.1192/bjp.bp.114.157123). Pharmaceuticals; 2007 (https://www.accessdata. 212. Stallman HM, Allen A. Acute suicide prevention: fda.gov/drugsatfda_docs/nda/2007/016608s098,0 a systematic review of the evidence and 20712s029,021710_ClinRev.pdf). implications for clinical practice. J Affect Disord 204. Meador KJ. Effects of in utero antiepileptic drug Rep. 2021;5:100148 (https://doi.org/10.1016/j. exposure. Epilepsy Curr. 2008;8(6):143–7 (https:// jadr.2021.100148). doi.org/10.1111/j.1535-7511.2008.00273.x). 213. Nuij C, Van Ballegooijen W, De Beurs D, Juniar 205. Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A. D, Erlangsen A, Portzky G et al. Safety planning- Valproate for acute mania. Cochrane Database type interventions for suicide prevention: meta- Syst Rev. 2019;(10):CD004052. analysis. Br J Psychiatry. 2021;219(2):419–26 (https://doi.org/10.1192/bjp.2021.50).",
  "gloss_vi": "Mental health gap action programme (mhgap) guideline for mental, neurological and substance use disorders 201. ciray ro, hancer p, tuncturk m, emiroglu 209.",
  "source": "WHO mhGAP-IG 2023",
  "url": "https://www.who.int/",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "management"
    ],
    "life_topics": [
      "work"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "high"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders 201. Ciray RO, Hancer P, Tuncturk M, Emiroglu 209. mhGAP operations manual. Geneva: World NI. [Placebo-controlled pharmacological Health Organization; 2018 (https://iris.who.int/ trials in child and adolescents with bipolar handle/10665/275386). disorder manic episode (BPD-ME): systematic 210. Bighelli I, Rodolico A, García-Mieres H, Pitschel- review, meta-analysis and a meta-regression Walz G, Hansen WP, Schneider-Thoma J et al. on placebo response] (in Turkish). Turkish J Psychosocial and psychological interventions Clinical Psychiatry. 2020;23:375–85 (https://doi. for relapse prevention in schizophrenia: a org/10.5505/kpd.2020.45822). systematic review and network meta-analysis. 202. Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Lancet Psychiatry. 2021;8(11):969–80 (https://doi. Nomura I et al. Pharmacological treatment for org/10.1016/S2215-0366(21)00243-1). bipolar mania: a systematic review and network 211. Oud M, Mayo-Wilson E, Braidwood R, Schulte meta-analysis of double-blind randomized P, Jones SH, Morriss R et al. Psychological controlled trials. Mol Psychiatry. 2022;27(2):1136– interventions for adults with bipolar disorder: 44 (https://doi.org/10.1038/s41380-021-01334-4). systematic review and meta-analysis. Br J 203. Farkas R, Feeney J. Clinical review, adverse events: Psychiatry. 2016;208(3):213–22 (https://doi. carbamazepine. East Hanover (NJ): Novartis org/10.1192/bjp.bp.114.157123). Pharmaceuticals; 2007 (https://www.accessdata. 212. Stallman HM, Allen A. Acute suicide prevention: fda.gov/drugsatfda_docs/nda/2007/016608s098,0 a systematic review of the evidence and 20712s029,021710_ClinRev.pdf). implications for clinical practice. J Affect Disord 204. Meador KJ. Effects of in utero antiepileptic drug Rep. 2021;5:100148 (https://doi.org/10.1016/j. exposure. Epilepsy Curr. 2008;8(6):143–7 (https:// jadr.2021.100148). doi.org/10.1111/j.1535-7511.2008.00273.x). 213. Nuij C, Van Ballegooijen W, De Beurs D, Juniar 205. Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A. D, Erlangsen A, Portzky G et al. Safety planning- Valproate for acute mania. Cochrane Database type interventions for suicide prevention: meta- Syst Rev. 2019;(10):CD004052. analysis. Br J Psychiatry. 2021;219(2):419–26 (https://doi.org/10.1192/bjp.2021.50). Mental health gap action programme (mhgap) guideline for mental, neurological and substance use disorders 201. ciray ro, hancer p, tuncturk m, emiroglu 209."
}